loading
전일 마감가:
$3.13
열려 있는:
$3.1035
하루 거래량:
4,424
Relative Volume:
0.15
시가총액:
$5.73M
수익:
$770.00K
순이익/손실:
$-38.84M
주가수익비율:
-0.2256
EPS:
-14.2049
순현금흐름:
$-43.02M
1주 성능:
-16.78%
1개월 성능:
-52.81%
6개월 성능:
-31.83%
1년 성능:
-64.77%
1일 변동 폭
Value
$3.1035
$3.24
1주일 범위
Value
$3.1035
$3.9899
52주 변동 폭
Value
$3.1035
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
명칭
Lyra Therapeutics Inc
Name
전화
617-373-4600
Name
주소
480 ARSENAL WAY, WATERTOWN, MA
Name
직원
87
Name
트위터
@LyraTx
Name
다음 수익 날짜
2025-03-12
Name
최신 SEC 제출 서류
Name
LYRA's Discussions on Twitter

LYRA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
LYRA
Lyra Therapeutics Inc
3.23 5.56M 770.00K -38.84M -43.02M -14.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
433.34 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
747.89 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
442.80 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
919.59 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
199.60 42.58B 447.02M -1.18B -906.14M -6.1812

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-07 다운그레이드 BofA Securities Buy → Underperform
2024-05-07 다운그레이드 H.C. Wainwright Buy → Neutral
2024-05-07 다운그레이드 Jefferies Buy → Hold
2024-05-06 다운그레이드 William Blair Outperform → Mkt Perform
2023-10-06 재개 BTIG Research Buy
2023-08-31 개시 H.C. Wainwright Buy
2022-05-24 개시 Cantor Fitzgerald Overweight
2020-05-26 개시 BTIG Research Buy
2020-05-26 개시 BofA/Merrill Buy
2020-05-26 개시 Jefferies Buy
2020-05-26 개시 William Blair Outperform
모두보기

Lyra Therapeutics Inc 주식(LYRA)의 최신 뉴스

pulisher
07:22 AM

Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com

07:22 AM
pulisher
Nov 20, 2025

Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de

Nov 15, 2025
pulisher
Nov 14, 2025

PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus

Nov 14, 2025
pulisher
Nov 14, 2025

What indicators show strength in Lyra Therapeutics Inc.2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Major Shareholder Sells Thousands of Lyra Therapeutics Shares! - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

BTIG reiterates Neutral rating on Lyra Therapeutics stock after Q3 results - Investing.com Canada

Nov 13, 2025
pulisher
Nov 12, 2025

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com

Nov 12, 2025
pulisher
Nov 12, 2025

Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks - TipRanks

Nov 12, 2025

Lyra Therapeutics Inc (LYRA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Lyra Therapeutics Inc 주식 (LYRA) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 12 '25
Sale
4.06
8,745
35,499
17,239
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 11 '25
Sale
4.31
5,320
22,954
18,122
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 06 '25
Sale
5.18
32,149
166,529
22,521
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 07 '25
Sale
4.75
19,739
93,695
20,528
PERCEPTIVE ADVISORS LLC
10% Owner
Nov 10 '25
Sale
4.54
18,502
83,995
18,659
$38.82
price up icon 1.07%
$30.36
price up icon 1.08%
$102.01
price up icon 0.33%
$97.38
price up icon 0.71%
biotechnology ONC
$344.38
price down icon 1.18%
$199.60
price down icon 0.21%
자본화:     |  볼륨(24시간):